NeutriSci Announces NeuEnergy™ Retail Distribution Relationship with the University of Colorado Boulder
Vancouver, BC – NeutriSci International Inc. (TSX-V:NU) (the “Company” or “NeutriSci”) is pleased to announce a NeuEnergy™ retail distribution relationship with the University of Colorado Boulder (“CU-Boulder”).
The University of Colorado Boulder is the flagship university of the state of Colorado. Founded in 1877, the university consists of nine colleges and schools and enrolls over 30,000 students. CU-Boulder’s cultural offerings attract 385,000 people to campus annually, and another 110,000 attend CU-Boulder educational outreach programs across Colorado.
NeuEnergy™ is an energy product designed to deliver enhanced energy, focus and mental clarity with no sugar, calories or crash typically associated with energy products. The efficacy of NeuEnergy™ is based on a molecular combination of pterostilbene and a low dose of caffeine. The resulting co-crystal provides a novel, next-generation alternative to high-dose caffeine products.
To find out more about NeuEnergy visit www.getneuenergy.com.
Glen Rehman, President of NeutriSci, stated: “We are very pleased to be able to announce this new retail distribution relationship. NeuEnergy™ is a product that will provide students the extended energy boost and focus that they are looking for with responsible ingredients and responsible levels of caffeine all backed by science and clinical studies. NeuEnergy™ is the perfect fit for many of the low caffeine initiatives that are being adopted universities around the country. We are proud to be at the forefront of these changes. This new partnership represents the beginning of a disruptive change in the acceptance of highly caffeinated energy drinks. We have the belief that this adoption represents only the first of many.”
Mr Rehman added, “In addition to our strong retail network we have seen a growing demand from organizations that have a desire to move away from offering highly caffeinated energy products; NeuEnergy™ offers a healthier alternative.”
About NeutriSci International Inc.
NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci has focused on the development of several breakthrough nutraceutical products with an initial focus on areas such as heart and cholesterol health, sleep deprivation therapies, immune defense as well as men’s prostate and sexual health. NeutriSci continues to build strong relationships and distribution channels for its BluScience™ and NeuEnergy™ products with retailers throughout the United States. NeutriSci is focusing efforts in strengthening sustainable sales models with Convenience, Chain Drug, Mass Market and Supermarket retailers. For more information, visit: www.neutrisci.com.
On Behalf of the Board of Directors of
NEUTRISCI INTERNATIONAL INC.
NeutriSci International Inc.
Tel: (403) 264-6320
Investor Relations Contact:
KIN Communications Inc
Fred Leigh, VP Investor Relations
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.